期刊文献+

对比高龄冠心病合并房颤患者不同抗栓方案的临床效果 被引量:3

下载PDF
导出
摘要 目的探究高龄冠心病合并心房颤动(房颤)患者不同抗栓方案的临床效果。方法 90例高龄冠心病合并房颤患者,随机分为对照组及观察组,每组45例。对照组给予阿司匹林治疗,观察组给予华法林联合阿司匹林治疗。比较两组患者的血栓事件发生情况和出血事件发生情况。结果治疗后,观察组患者发生1例下肢动脉栓塞,血栓事件发生率为2.22%。对照组患者发生5例下肢动脉栓塞, 2例急性心肌梗死, 3例新发脑梗死,血栓事件发生率为22.22%。观察组患者的血栓事件发生率低于对照组,差异有统计学意义(χ~2=8.389, P<0.05)。观察组患者的出血事件发生率为35.56%,对照组患者的出血事件发生率为24.44%,两组患者的出血事件发生率比较,差异无统计学意义(P>0.05)。结论高龄冠心病合并房颤患者采用华法林联合阿司匹林的方式进行抗栓治疗,能够减少血栓事件的发生,提高治疗效果。
出处 《中国现代药物应用》 2019年第9期100-101,共2页 Chinese Journal of Modern Drug Application
  • 相关文献

参考文献7

二级参考文献33

  • 1许永顺.房颤合并冠心病患者PCI术后抗栓策略分析[J].河北北方学院学报(自然科学版),2014,30(3):116-118. 被引量:5
  • 2Baigent C, Blackwell L, Collins R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomized trials. Lancet, 2009, 373: 1849-1860.
  • 3Thrombosis prevention trials: randomized trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework. Lancet, 1998, 351: 233-241.
  • 4Baigent C, Sudlow C, Collins R, et al. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ, 2002, 324: 71-86.
  • 5Gent M, Beaumont D, Blanchard J, et al. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348: 1329-1339.
  • 6Pokushalov E, Romanov A, Katritsis DG, et al. Ganglionated plexus ablation vs linear ablation in patients undergoing pulmonary vein isolation for persistent/long-standing persistent atrial fibrillation: a randomized comparison. Heart Rhythm, 2013, 10: 1280-1286.
  • 7Mant J, Hobbs FD, Fletcher K, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomized controlled trial. Lancet, 2007, 370: 493-503.
  • 8Friberg L, Rosenqvist M, Lip GY, et al. Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study. Circulation, 2012, 125: 2298-2307.
  • 9Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation, 2006, 114: 257-354.
  • 10Hart RG, Pearce LA, Aguilar MI, et al. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med, 2007, 146: 857-867.

共引文献68

同被引文献22

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部